Key result
Perioperative magnesium significantly delayed the time for first analgesic requirement in children undergoing tonsillectomy (SMD 0.75; 95% CI 0.20-1.31; P=.0079).
Why the study?
Does perioperative magnesium reduce postoperative morbidities in children undergoing tonsillectomy?
Meta-Analysis (n=615)
Does perioperative magnesium reduce postoperative morbidities in children undergoing tonsillectomy?
Perioperative magnesium administration, regardless of route, significantly delays the need for first analgesic and reduces laryngospasm and agitation in children undergoing tonsillectomy.
Supports perioperative magnesium to delay first analgesia after pediatric tonsillectomy; extends evidence for reduced postoperative morbidity in children.
Objectives The perioperative administration of magnesium is known to reduce postoperative morbidities in adults, such as pain, agitation, and laryngospasm. The objective is to assess the effects of perioperative magnesium as the adjuvant to tonsillectomy as compared with tonsillectomy in children. Data Source Five databases (PubMed, SCOPUS, Embase, Web of Science, Cochrane). Method Two authors independently searched databases up to January 2017. We compared perioperative magnesium administration (magnesium groups) with no administration of magnesium (control group). The following outcomes were measured: postoperative pain intensity, analgesics administration, or other morbidities (laryngospasm, agitation, postoperative bleeding) in the postoperative 24 hours. Additionally, to evaluate the discrepancy of effects according to different administration routes, subgroup analyses regarding effects according to systemic or local administration of magnesium were performed. Results Nine prospective randomized controlled studies (n = 615) that evaluated the effect of magnesium in children having undergone tonsillectomy met inclusion criteria. Compared with control group, the time for first analgesic requirement was significantly delayed in magnesium groups (standardized mean difference = 0.75; 95% CI, 0.20-1.31; P = .0079). Laryngospasm (log odds ratio = -1.09; 95% CI,-2.11 to -0.07; P = .0362) and agitation score (standardized mean difference = -0.67; 95% CI, -0.97 to -0.36; P < .0001) in the recovery room also significantly decreased in magnesium groups. In subgroup analyses regarding pain and laryngospasm-related measurements, local administration of magnesium was shown to be more effective at reducing postoperative morbidities. Conclusions Perioperative magnesium regardless of route may offer pain, agitation, and laryngospasm relief without adverse effects in pediatric tonsillectomy. Based on the high heterogeneity of results within some parameters, further studies need to be performed to affirm these results.
No takes yet. Share an insight, caveat, or question.
Cho et al. (2017) conducted a meta-analysis in posttonsillectomy morbidity in children (n=615). Perioperative magnesium vs. no administration of magnesium was evaluated on time for first analgesic requirement (SMD 0.75, 95% CI 0.20-1.31, p=.0079). Perioperative magnesium significantly delayed the time for first analgesic requirement in children undergoing tonsillectomy (SMD 0.75; 95% CI 0.20-1.31; P=.0079).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: